Immune-excluded and immune-suppressive tumor microenvironments: mechanisms, spatial biomarkers, and therapeutic rewiring
{{output}}
Background: Immune checkpoint inhibitors have improved outcomes in several malignancies, yet durable benefit remains limited in most solid tumors because many lesions exhibit immune-excluded or immune-suppressive tumor microenvir... ...
